Description
EMPIGET-M Tablets 12.5mg + 500mg (28’s pack) combine Empagliflozin and Metformin to support effective management of type 2 diabetes mellitus. Each tablet contains 12.5mg of Empagliflozin, an SGLT2 inhibitor that promotes glucose excretion through the kidneys, and 500mg of Metformin, which reduces hepatic glucose production and improves insulin sensitivity.
This dual-action medication aids in controlling blood sugar levels, supports weight management, and may provide cardiovascular benefits. The 28-tablet pack offers a convenient supply for ongoing treatment.
Manufactured under stringent quality standards, EMPIGET-M Tablets ensure safety, efficacy, and consistent therapeutic effects. Patients should follow their healthcare provider’s instructions and maintain a balanced diet and exercise routine during treatment.
Reviews
There are no reviews yet.